Seeing Is Believing
Currently out of the existing stock ratings of Debjit Chattopadhyay, 126 are a BUY (90.65%), 13 are a HOLD (9.35%).
Analyst Debjit Chattopadhyay works at GUGGENHEIM with a stock forecast success ratio of 49.49% fulfilled within 216.36 days on average.
Debjit Chattopadhyay’s has documented 297 price targets and ratings displayed on 26 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on BOLD, Audentes Therapeutics at 22-Apr-2024.
Analyst best performing recommendations are on HARP (HARPOON THERAPEUTICS).
The best stock recommendation documented was for MGNX (MACROGENICS) at 5/6/2020. The price target of $22 was fulfilled within 1 day with a profit of $3.15 (12.52%) receiving and performance score of 125.25.
Average potential price target upside
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
25
$20.44 (448.25%)
90
1 months 27 days ago
0/3 (0%)
$19.41 (347.23%)
Hold
8
$3.44 (75.44%)
1 months 30 days ago
0/3 (0%)
$2.25 (39.13%)
Buy
28
$23.44 (514.04%)
3 months 12 days ago
0/3 (0%)
$22.12 (376.19%)
Buy
50
$45.44 (996.49%)
56
8 months 26 days ago
1/4 (25%)
$39.94 (397.02%)
66
Hold
14
$9.44 (207.02%)
10 months 6 days ago
2/4 (50%)
$2.86 (25.67%)
148
Which stock is Debjit Chattopadhyay is most bullish on?
Which stock is Debjit Chattopadhyay is most reserved on?
What Year was the first public recommendation made by Debjit Chattopadhyay?